Ask AI
ProCE Banner Activity

EBONI: Real-world LA CAB PrEP Implementation Among Black Women in the United States

Conference Coverage
Slideset

In phase IV effectiveness-implementation study among cisgender and transgender Black women at clinical practice sites located within US “Ending the HIV Epidemic” jurisdictions, LA CAB PrEP had high effectiveness and acceptability with no incident HIV cases, a low rate of discontinuation for adverse events, and high rates of participant satisfaction after 12 months.

Released: March 02, 2026

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by independent educational grants from Gilead Sciences, Inc., Merck & Co., Inc., Rahway, NJ, USA, and ViiV Healthcare.

Gilead Sciences, Inc.

Merck & Co., Inc., Rahway, NJ, USA

ViiV Healthcare

Target Audience

This program is intended for physicians, pharmacists, registered nurses, and other healthcare professionals who care for people living with or at risk of HIV infection.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Appropriately apply and counsel patients regarding the clinical role(s) of new and investigational ART regimens and strategies

  • Devise HIV management strategies based on the results of recent clinical studies of established antiretroviral agents

  • Integrate the latest scientific findings to develop and optimize effective HIV prevention interventions